Navigation Links
FDA's Grace McNally to Appear at ISPE Facilities Conference
Date:2/8/2012

TAMPA, Fla., Feb. 8, 2012 /PRNewswire-USNewswire/ -- ISPE announced today that the US FDA's Grace McNally will appear at the Society's upcoming Lessons from 483s: Enhancing Efficiency, Quality and cGMP Compliance Conference. McNally will add her expertise to that of other industry and regulatory experts at the two-day event, which will review recent regulatory citations (FDA-483s) and provide guidance on how the citations can be avoided. This conference will give pharmaceutical professionals the vital insights into regulatory issues they need in order to avoid the costly and damaging consequences that can result from 483 citations, such as recalls and plant shutdowns.

(Logo: http://photos.prnewswire.com/prnh/20120208/DC49497LOGO)

Educational content will address 483s in the context of biotech, oral solid dosage processing and containment, and process validation. The conference, part of ISPE's Facilities of the Future conference series, will take place in Tampa, Florida USA on 27 – 28 February 2012.

"As the technical voice of manufacturing and engineering in the pharmaceutical industry, ISPE is committed to presenting programs that facilitate relevant dialogue and the sharing of best practices among industry leaders, manufacturing experts and leading regulators," said ISPE's new President and CEO Nancy Berg. "At a time when manufacturing operations are under tremendous pressures to improve effectiveness, deliver quality and reduce costs, ISPE is responding with new programs and conference formats that feature dynamic and focus
'/>"/>

SOURCE ISPE
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DMC Sinai-Grace Selects Loopback Communications Readmission Reduction™ Services
2. AstraZeneca and Grace Hill Neighborhood Health Centers, Inc. Provide Medicines to Missouris Uninsured
3. Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS
4. "7th Heaven" and "Game Time" Star Catherine Hicks to Appear at the National Community Pharmacists Associations Convention October 10, 2011 in Nashville for Education Effort to Help Prevent Prescription Medication Abuse
5. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
6. Gloria Gaynor to Appear at AARPs Orlando@50+ National Event & Expo
7. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
8. Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy
9. Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin
10. Elbow Ligament Reconstruction Appears Not to Affect Future Professional Advancement in Baseball
11. Pharmaceutics International, Inc. (Pii) Announces cGMP Aseptic Facilities Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)...   Santa Clara dentist , Dr. Alan ... Invisalign. Invisalign is an orthodontic system that uses clear ... the orthodontic treatment of choice for older teens and ... For a limited time, patients can try Invisalign for ... usual cost. This offer cannot be combined, and some ...
(Date:9/2/2014)... DALLAS , September 2, 2014 ... Chromatography Column Market by Type (Empty, Pre-packed, Analytical, Preparative), by Material ... Flash Chromatography, UFLC), TLC,SFC] - Forecast to 2018", published by ... Million in 2013. It is poised to grow at ... Million by 2018. Browse 90 market ...
(Date:9/2/2014)... Spain , September 2, 2014 ... decisions, including patients, quality of life and treatment satisfaction ... 2 ]   ... ESC Congress 2014, 02 September 2014, Barcelona, ... results of the PREvention oF thromboembolic events-European Registry in ...
Breaking Medicine Technology:Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 2One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 3One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 4One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 5One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 6One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 7One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 8
(Date:9/2/2014)... York, NY (PRWEB) September 02, 2014 ... VisitandCare.com , was designed to help doctors manage ... practices to boost patient conversion rates and clink revenue. ... a 60 percent increase in sales revenue and a ... one-of-a-kind CRM software in their own healthcare practices. , ...
(Date:9/2/2014)... California, San Diego School of Medicine have identified an ... The findings, reported in the current issue of PNAS, ... mortality worldwide. An estimated 40,000 women in America will ... American Cancer Society. , "The take-home message of the ... target breast cancer metastasis through a pathway regulated by ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 For the ... IT security and network services company, has been named ... Inc. magazine's Inc. 5000 list highlights America's fastest growing ... year since the list inception in 2007. , Landing ... grown 144 percent over the past three years. , ...
(Date:9/2/2014)... (trade name: Betmiga) has been approved since December 2012 ... an early benefit assessment pursuant to the Act on ... the German Institute for Quality and Efficiency in Health ... added benefit over the appropriate comparator therapy specified by ... advantage with regard to side effects: Dry mouth was ...
(Date:9/2/2014)... A New York City based company is ... yet revolutionary, product that will have far-reaching, ... care costs for Americans. , REMIND-A-CAP™ is ... control in the user's hands. It's a simple device ... date of intake by simply turning a knob. No ...
Breaking Medicine News(10 mins):Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 2Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 3Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 4Health News:Enzyme controlling metastasis of breast cancer identified 2Health News:CentraComm Named to Inc. 5000 for 8th Consecutive Year 2Health News:Mirabegron for overactive bladder: Added benefit not proven 2Health News:Mirabegron for overactive bladder: Added benefit not proven 3Health News:REMIND-A-CAP™ , A New York City Based Company Invents Groundbreaking Prescription Cap to Curb Non-Adherence 2
... first discovered in China nearly 5000 years ago, has ... heart disease, stroke and certain types of cancer. Researchers ... two compounds found in green tea, EGCG (epigallocatchin gallate) ... blocking the enzyme that destroys cartilage. Dr David Buttle, ...
... Venous thromboembolism is a condition which causes clotting in ... five- to 10-day course of heparin followed by three ... the problem with this treatment is that once the ... rates of this problem are reduced if the patient ...
... in the February issue of the British Medical Journal has ... at risk of heart disease later in life than those ... infant in Scotland during the years 1981-85, were identified as ... or repeated miscarriages. Then, during 1981 to 1999, the researchers ...
... a common problem in the knees, is a form ... change. A key problem involved in in these type ... salt called hyaluronan within the fluid that moisturizes the ... injections are being given to humans since 1987, after ...
... in appetite control, called ghrelin, has been identified by ... have demonstrated the effect of the hormone on the ... specialized neurons in the hypothalamus involved in weight regulation. ... the ability to stimulate feeding when introduced to specialized ...
... not all that well understood, but is believed to ... winter months. Winter depression involves suffering from feelings of ... and nights get shorter. Other SAD symptoms include overeating, ... than usual. Researchers have now found that light therapy// ...
Cached Medicine News:Health News:Treatment over a longer period for blood clotting 2Health News:Miscarriage during pregnancy and heart disease linked 2Health News:Scientists locate key hormone involved in appetite control 2
Key periosteal elevators, blade width 1" (25 mm), total length 7 1/2" (191 mm)....
Cushing-Hopkins periosteal elevator, Gutsch handle, blade width 7/16" (11 mm), length 7 5/8" (194 mm)....
Cushing Little Joker periosteal elevators, solid handle, blade width 1/4" (6 mm), length 7 1/2" (191 mm)....
Lederer periosteal elevators....
Medicine Products: